	US 12,232,961 B2
	Mitral valve spacer device
Michael D. Franklin, Irvine, CA (US); Matthew T. Winston, Aliso Viejo, CA (US); Lauren R. Freschauf, Mission Viejo, CA (US); Eric Robert Dixon, Villa Park, CA (US); and Yoon Hee Kwon, Mission Viejo, CA (US)
Assigned to EDWARDS LIFESCIENCES CORPORATION, Irvine, CA (US)
Filed by Edwards Lifesciences Corporation, Irvine, CA (US)
Filed on Jul. 15, 2022, as Appl. No. 17/865,712.
Application 17/865,712 is a continuation of application No. 16/351,297, filed on Mar. 12, 2019, granted, now 11,389,297.
Claims priority of provisional application 62/656,533, filed on Apr. 12, 2018.
Prior Publication US 2022/0346946 A1, Nov. 3, 2022
Int. Cl. A61F 2/24 (2006.01)

CPC A61F 2/246 (2013.01) [A61F 2/2463 (2013.01); A61F 2/2409 (2013.01); A61F 2/2412 (2013.01); A61F 2/2436 (2013.01); A61F 2/2445 (2013.01); A61F 2/2457 (2013.01); A61F 2/2466 (2013.01); A61F 2210/0014 (2013.01); A61F 2220/0008 (2013.01); A61F 2220/0016 (2013.01); A61F 2250/0003 (2013.01); A61F 2250/0036 (2013.01); A61F 2250/0069 (2013.01)]

6 Claims

1. A method for improving coaptation of native heart valve leaflets comprising:

advancing a delivery apparatus and an implantable prosthetic device into a body of a patient, the implantable prosthetic device comprising an adjustable spacer;

positioning the adjustable spacer between the native heart valve leaflets such that the adjustable spacer is offset from an area of regurgitation;

adjusting a size of the adjustable spacer while the adjustable spacer is disposed between the native heart valve leaflets so that the adjustable spacer assumes an asymmetric configuration such that the adjustable spacer blocks the area of regurgitation;

wherein the adjustable spacer has a first side adjustable in size and a second side adjustable in size; and

wherein the first side is adjusted in size independently of the second side.